Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipo-AB vs Amphotericin B in Cryptococcal Meningitis
NCT02136030Unknown
- Sponsor
- TTY Biopharm Company Limited
- Start
- Feb 2011
- Primary completion
- Dec 2015
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of liposomal amphotericin b in cryptococcal meningitis (2 arms), sponsored by TTY Biopharm Company Limited. Primary endpoint: Successful response rate at Day 14. Status: unknown.
02
Drugs
liposomal amphotericin b
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT02136030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136030.